4//SEC Filing
Casdin Capital, LLC 4
Accession 0000919574-25-005051
CIK 0000834365other
Filed
Aug 20, 8:00 PM ET
Accepted
Aug 21, 9:10 PM ET
Size
11.2 KB
Accession
0000919574-25-005051
Insider Transaction Report
Form 4
Casdin Partners Master Fund, L.P.
10% Owner
Transactions
- Sale
Common Stock, par value $0.001 per share
2025-08-15$24.40/sh−500,000$12,200,000→ 6,707,165 total(indirect: See footnote.)
Casdin Eli
10% Owner
Transactions
- Sale
Common Stock, par value $0.001 per share
2025-08-15$24.40/sh−500,000$12,200,000→ 6,707,165 total(indirect: See footnote.)
Casdin Capital, LLC
10% Owner
Transactions
- Sale
Common Stock, par value $0.001 per share
2025-08-15$24.40/sh−500,000$12,200,000→ 6,707,165 total(indirect: See footnote.)
Casdin Partners GP, LLC
10% Owner
Transactions
- Sale
Common Stock, par value $0.001 per share
2025-08-15$24.40/sh−500,000$12,200,000→ 6,707,165 total(indirect: See footnote.)
Footnotes (1)
- [F1]The securities are owned directly by Casdin Partners Master Fund, L.P. (the "Master Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC ("Casdin Capital"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC ("Casdin GP"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin Capital and Casdin GP.
Documents
Issuer
BIOLIFE SOLUTIONS INC
CIK 0000834365
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001534261
Filing Metadata
- Form type
- 4
- Filed
- Aug 20, 8:00 PM ET
- Accepted
- Aug 21, 9:10 PM ET
- Size
- 11.2 KB